FDA Prioritizes Reviews Of Opioid Overdose ANDAs

May 26, 2017-ogden Utah USA: naloxone and narcan nasal sprays are now available over the counter to prevent drug overdoses. - Illustration
Narcan is among the reference brands for which the FDA is accelerating ANDA review • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Regulation

More from Policy & Regulation